Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A novel translational in-silico indication discovery framework identifies indications and predictive biomarkers for cenerimod

ABSTRACT: A novel translational in-silico indication discovery framework identifies indications and predictive biomarkers for cenerimod

PROVIDER: PRJNA1244372 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR32926300.fastq.gz	Fastqsanger.gz
	SRR32926301.fastq.gz	Fastqsanger.gz
	SRR32926303.fastq.gz	Fastqsanger.gz
	SRR32926305.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 31

Similar Datasets

A novel translational in-silico indication discovery framework identifies indications and predictive biomarkers for cenerimod

Project description:To fully explore a drug candidate's therapeutic potential, assessing its effectiveness across all possible diseases is essential. While traditional approaches match drug mechanisms to disease pathophysiology, they are limited by the high costs and slow progress of preclinical and clinical trials. This study introduces a novel in silico framework to identify new indications for drug candidates or repurpose approved drugs by analyzing their effects on gene expression in patients or animal models compared to controls. The framework integrate data from 13,602 patient samples across 146 diseases with drug candidate tested in preclinical models and use a neural network to reduce noise and improve sensitivity. The framework was exemplified with cenerimod, a S1P1 receptor modulator, which predicted its efficacy in immune-related diseases such as SLE, Psoriasis, and Crohn’s disease and kidney transplantation complications. Additionally, it identified six genes predictive of maximal clinical response in SLE patients, validated using RNA-seq data from a phase 2b cenerimod trial.

2025-05-31 | GSE293404 | GEO

In silico discovery of the blood cell interactome

Project description:In silico discovery of the blood cell interactome

| PRJNA817538 | ENA

Predictive computational obesity risk framework through integration of gene expression profiles and genetic risk score.

Project description:Predictive computational obesity risk framework through integration of gene expression profiles and genetic risk score.

| PRJNA431452 | ENA

In silico discovery of the blood cell interactome [Affymetrix]

Project description:In silico discovery of the blood cell interactome [Affymetrix]

| PRJNA817546 | ENA

In silico discovery of the blood cell interactome [microRNA]

Project description:In silico discovery of the blood cell interactome [microRNA]

| PRJNA817533 | ENA

In silico nano-dissection: defining cell type specificity at transcriptional level in human disease (tubulointerstitium)

Project description:To identify genes with cell-lineage-specific expression not accessible by experimental micro-dissection, we developed a genome-scale iterative method, in-silico nano-dissection, which leverages high-throughput functional-genomics data from tissue homogenates using a machine-learning framework. This study applied nano-dissection to chronic kidney disease and identified transcripts specific to podocytes, key cells in the glomerular filter responsible for hereditary proteinuric syndromes and acquired CKD. In-silico prediction accuracy exceeded predictions derived from fluorescence-tagged-murine podocytes, identified genes recently implicated in hereditary glomerular disease and predicted genes significantly correlated with kidney function. The nano-dissection method is broadly applicable to define lineage specificity in many functional and disease contexts. We applied a machine-learning framework on high-throughput gene expression data from human kidney biopsy tissue homogenates and predict novel podocyte-specific genes. The prediction was validated by Human Protein Atlas at protein level. Prediction accuracy was compared with predictions derived from experimental approach using fluorescence-tagged-murine podocytes.

2013-08-06 | E-GEOD-47184 | biostudies-arrayexpress

In silico nano-dissection: defining cell type specificity at transcriptional level in human disease (glomeruli)

2013-08-06 | E-GEOD-47183 | biostudies-arrayexpress

In silico nano-dissection: defining cell type specificity at transcriptional level in human disease (tubulointerstitium)

2013-08-06 | GSE47184 | GEO

In silico nano-dissection: defining cell type specificity at transcriptional level in human disease (glomeruli)

2013-08-06 | GSE47183 | GEO

in silico Serotyping

Project description:A set of 520 genomes where serotyped with two in silico typing tools

| PRJEB30317 | ENA